Open Demat Account
Become a
New
Partner
Financial
Services
Financial
Planning
Analyse
Portfolio
Investment
Platforms
Login
Flip
FundsGenie
Smartfolios
PMS
TraderX
MyGeojit
Open Demat Account
Support
Equity
Mutual Funds
Portfolio Management
Currency Futures
IPO
Smartfolios
NEW
Sovereign Gold Bond
Commodity
Insurance
Depository Services
Global Investments
NEW
Margin Trading Funding
Private Wealth
NRI Services
Alternative Investment Funds
FundsGenie for Mutual Funds
Mutual Funds Sahi Hai!
Login to FundsGenie
Or Download the Mobile App
Equity
Margin Trading Funding
Smartfolios
NEW
Currency Futures
Depository Services
Commodity
IPO
Sovereign Gold Bond
To avail the service, you will be redirected to loans.geojitcredits.com
Continue
Close
Search
ALL
Company
News
NAV
Site Search
Please wait ...
Home
Equity
Index Details -Pharmaceuticals - Indian - Bulk Drugs & Formln
Share
Novartis India Ltd Share Price
Pharmaceuticals - Indian - Bulk Drugs & Formln
Buy
Ask Expert
Background
Balance sheet
Profit & Loss
Quarterly Results
Share Prices
Bonus History
Capital History
Key Financial Ratios
Director's Report
Score Board
Peer Comparison
Deliverable Volumes
NSE
BSE
672.25
858.35
Date :
Oct 25,2023 EOD
+0.00
(0.00 )
-0.58
(-5.05)
1D
1W
1M
3M
1Y
Stock Price Details
Open Price
(₹)
691.05
Buy (size)
0.00(x0)
Sell (size)
672.25(×249)
Buy Qty
0
Sell Qty
249
Today's High
(₹)
698.20
Today's Low
(₹)
668.35
52 Week High
(₹)
698.20
52 Week Low
(₹)
0.00
Market Statistics
Div Yield (%)
2.91
EPS
41.63
Book Value
317.92
Market Cap
2119.33
Face Value
5
Market Lot
1
AGM Date
Jul
Closure Date
Jul
ISIN No
INE234A01025
Share Holding Pattern
Total Foreign (Promoter & Group)
17450680
Indian (Promoter & Group)
0
Total of Promoter
17450680
Non Promoter (Institution)
177843
Non Promoter (Non-Institution)
7062274
Total Non Promoter
7240117
Total Promoter & Non Promoter
24690797
Custodians(Against Depository Receipts)
0
Grand Total
24690797
News
Novartis India Ltd
Novartis India to conduct board meeting
01-Oct-2025
Read More
Novartis India Ltd
Novartis India to conduct board meeting
Novartis India will hold a meeting of the Board of Directors of the Company on 28 October 2025.
Novartis India Ltd
Novartis India Ltd - Closure of Trading Windo..
30-Sep-2025
Read More
Novartis India Ltd
Novartis India Ltd - Closure of Trading Window
Pursuant to the 'Code of Conduct' to regulate monitor and report share trading by Designated Person and their immediate relative (Code) read with the application provisions of the SEBI (Prohibition of Insider Trading) Regulations 2015 as amended the Trading Window for dealing in shares of the Company by Designated Person / Insiders / Connected Persons and their immediate relatives will be closed with effect from Wednesday October 01 2025. The trading window will open 48 hours after the said financial results are declared to the Stock Exchange.
Novartis India Ltd
Novartis India Ltd - Board Meeting Intimation..
30-Sep-2025
Read More
Novartis India Ltd
Novartis India Ltd - Board Meeting Intimation for Inter Alia Considering The Unaudited Financial Results For The Half Year And Quarter Ended September 30 2025.
Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2025 inter alia to consider and approve The Meeting of the Board of Directors of Novartis India Limited is scheduled to be held on Tuesday October 28 2025 to inter alia consider the Unaudited Financial Results for the half year and quarter ended September 30 2025.
Novartis India Ltd
Novartis India Ltd - Announcement under Regul..
30-Jul-2025
Read More
Novartis India Ltd
Novartis India Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
Intimation of the publication of Financial Results for the quarter ended June 30 2025 in the Newspaper - Financial Express (English) and Navshakti (Marathi).
Novartis India Ltd
Novartis India standalone net profit rises 7...
29-Jul-2025
Read More
Novartis India Ltd
Novartis India standalone net profit rises 7.30% in the June 2025 quarter
Net profit of Novartis India rose 7.30% to Rs 27.62 crore in the quarter ended June 2025 as against Rs 25.74 crore during the previous quarter ended June 2024. Sales declined 5.14% to Rs 87.55 crore in the quarter ended June 2025 as against Rs 92.29 crore during the previous quarter ended June 2024.
Particulars
Quarter Ended
Jun. 2025
Jun. 2024
% Var.
Sales
87.55
92.29
-5
OPM %
31.11
25.97
-
PBDT
37.75
34.23
10
PBT
37.22
33.68
11
NP
27.62
25.74
7
Novartis India Ltd
Novartis India Ltd - Board Meeting Outcome fo..
29-Jul-2025
Read More
Novartis India Ltd
Novartis India Ltd - Board Meeting Outcome for Intimation About The Outcome Of The Board Meeting Held On July 29 2025 Inter Alia For The Approval Of Unaudited Financial Statements For The Quarter Ending As On June 30 2025.
Intimation about the Outcome of the Board Meeting held on July 29 2025 inter alia for the approval of the unaudited Financial Statements for the Quarter ending as on June 30 2025.
Novartis India Ltd
Novartis India Ltd - Unaudited Financial Resu..
29-Jul-2025
Read More
Novartis India Ltd
Novartis India Ltd - Unaudited Financial Results For The Quarter Ended As On June 30 2025.
Intimation for the Unaudited Financial Results for the Quarter ended as on June 30 2025.
Novartis India Ltd
Novartis India Ltd - Announcement under Regul..
29-Jul-2025
Read More
Novartis India Ltd
Novartis India Ltd - Announcement under Regulation 30 (LODR)-Change in Management
Intimation of the approval of the Board of Directors for the Appointment of Cost Auditor for the Financial Year 2025-26
Novartis India Ltd
Novartis India Ltd - Compliances-Certificate ..
14-Jul-2025
Read More
Novartis India Ltd
Novartis India Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Intimation of the Certificate dated July 10 2025 received from RTA under Regulation 74(5) of SEBI (DP) Regulations 2018
Novartis India Ltd
Novartis India Ltd - Announcement under Regul..
06-Jul-2025
Read More
Novartis India Ltd
Novartis India Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
This intimation is submitted for filing the advertisement post the dispatch of Notice of AGM to the Shareholders.
Corporate Details
Board of Directors
Incorporation Year
1947
Chairman
C Snook
Auditor
B S R & Co LLP
Face Value
5
Market Lot
1
Listing
BSE,MSEI,NSE,
Registered Office
Sandoz House Dr Annie Besant Road Worli MR Maharashtra Mumbai400018
Contact
Telephone: 91-022-50243000
Fax: 91-022-50243010
Chairman (Non-Executive)
C Snook
Independent Director
Sandra Martryes
SANKER PARAMESWARAN
Whole Time Director & Chief Financial Officer
Shilpa Joshi
Company Sec. & Compli. Officer
Chandni Maru
Independent Director
Gira Sardesai
Whole Time Director
Falin Majmudar
Mutual Fund Holdings
1-3
of 3
Scheme Name
Amount Invested (Cr )
% Net Assets
Total Nav (Cr)
Motilal Oswal BSE Healthcare ETF
0.01
0.04
32.76
Bandhan BSE Healthcare Index Fund
0.01
0.04
17.74
Motilal Oswal BSE 1000 Index Fund
0.00
0.00
51.70
FAQ
What is the share price of Novartis India Ltd today on NSE and BSE?
The Novartis India Ltd Share price on NSE is Rs.672.25 and BSE Rs.858.35 as on today
How to buy Novartis India Ltd shares Online?
You can easily open a Demat account online with Geojit and buy Novartis India Ltd shares through Flip/Selfie – Geojit’s advanced trading platform.
What is the Market Capitalization of Novartis India Ltd?
Market capitalization is a way of evaluating the value of a company. It refers to the total value of all a company's shares of stock. The market capitalization of Novartis India Ltd is 2119.33
What are the key financial ratios to analyse Novartis India Ltd Share Price?
Novartis India Ltd share can be evaluated based on following ratios as on March 2023
Shares P/E ratio: 20.62
ROE ratio: 13.19
Debt to Equity ratio: 0.01
EPS: 41.63
When did Novartis India Ltd gave bonus shares last?
The issue of bonus shares enhances the company's value and improve positions in the market by gaining the trust of existing shareholders. The Novartis India Ltd issued bonus shares last in 1990
What is the 52 week highest and lowest share price value of Novartis India Ltd?
The highest share price value is Rs. 698.20 and Lowest share price value is Rs. 0.00 for 52 week period for Novartis India Ltd.
Which ETF or Mutual Fund Holding has the highest amount invested with Novartis India Ltd?
Motilal Oswal BSE Healthcare ETF has the highest amount invested with Novartis India Ltd.
Which year Novartis India Ltd was incorporated?
Novartis India Ltd was incorporated in 1947
What is the stock symbol of Novartis India Ltd?
The stock symbol for Novartis India Ltd shares is NOVARTISINDIALTD.
Peer Comparison
Option Type
Balance Sheet
Financial Ratios
Profit & Loss
Select
Company Name
BSE Code
NSE Symbol
Aarti Pharmalabs Ltd
543748
AARTIPHARM
Accent Microcell Ltd
92465
ACCENTMIC
Accretion Pharmaceuticals Ltd
94000
ACCPL
Achyut Healthcare Ltd
543499
Not Listed
Advanced Enzyme Technologies Ltd
540025
ADVENZYMES
Akums Drugs & Pharmaceuticals Ltd
544222
AKUMS
Albert David Ltd
524075
ALBERTDAVD
Alembic Pharmaceuticals Ltd
533573
APLLTD
Alivus Life Sciences Ltd
543322
ALIVUS
Alkem Laboratories Ltd
539523
ALKEM
Please wait ...
Deliverable Volumes
Exchange
BSE
NSE
From Date
To Date
Date
Quantity Traded
Quantity Delivered
Change %
No Data Found For Deliverable Volume
Please wait ...